`
`IN THE UNITED STATES DISTRICT COURT
`FOR THE DISTRICT OF MASSACHUSETTS
`
`
`TEVA PHARMACEUTICALS
`INTERNATIONAL GMBH and
`TEVA PHARMACEUTICALS
`USA, INC.,
`
`
`Plaintiffs,
`
`
`v.
`
`ELI LILLY AND COMPANY,
`
`
`Defendant.
`
`
`
`
`Civil Action No.
`1:18-cv-12029-ADB
`
`
`
`
`
`
`
`JOINT STIPULATION AMENDING PROTECTIVE ORDER
`
`Plaintiffs Teva Pharmaceuticals International GmbH and Teva Pharmaceuticals USA, Inc.
`
`(collectively, “Teva”) and Defendant Eli Lilly and Company (“Lilly”) (all together, the “Parties”)
`
`have agreed to enter into this stipulation to amend the Stipulated Protective Order (ECF No. 381)
`
`to facilitate preparation for trial and trial presentation;
`
`WHEREAS, the Parties entered into a Stipulated Protective Order to expedite the flow of
`
`discovery material, facilitate the prompt resolution of any disputes over confidentiality, balance
`
`the Parties’ need for information to conduct this Litigation against their need to maintain the
`
`confidentiality of information entitled to be kept confidential;
`
`WHEREAS, the Parties agree that certain modifications to the confidentiality restrictions
`
`in the Stipulated Protective Order (ECF No. 381) are warranted to permit designated in-house
`
`counsel to participate in trial preparation activities and attend trial; and
`
`
`
`Case 1:18-cv-12029-ADB Document 528 Filed 10/14/22 Page 2 of 6
`
`WHEREAS, the Stipulated Protective Order (ECF No. 381) provides that the Court may
`
`modify the Protective Order at any time in the interests of justice, and to ensure that any
`
`proceedings before this Court is fair, efficient, and consistent with the public interest
`
`NOW THEREFORE, IT IS HEREBY STIPULATED AND AGREED, by and between
`
`the Parties hereto, and subject to the approval of the Court, the Stipulated Protective Order (ECF
`
`No. 381) is amended as follows:
`
`1.
`
`Material and information designated as “HIGHLY CONFIDENTIAL—OUTSIDE
`
`COUNSEL ONLY” pursuant to the Stipulated Protective Order may be disclosed to four (4)
`
`designated In-House Counsel, in accordance with Paragraphs 11 and 12, except that the In-House
`
`Counsel shall not be provided or otherwise possess copies (whether in electronic or paper form)
`
`of any Litigation Material designated “HIGHLY CONFIDENTIAL—OUTSIDE COUNSEL
`
`ONLY.” For clarity, the purpose of this amendment is to permit the Parties’ In-House designees
`
`to participate in trial preparation activities and attend trial when “HIGHLY CONFIDENTIAL—
`
`OUTSIDE COUNSEL ONLY” information is being discussed.
`
`2.
`
`The restrictions in Paragraph 6(b) of the Stipulated Protective Order shall apply to
`
`any In-House Counsel that becomes aware of “HIGHLY CONFIDENTIAL—OUTSIDE
`
`COUNSEL ONLY” information under this amendment, unless In-House Counsel has only become
`
`aware of financial information. For the avoidance of doubt, nothing in Paragraph 6(b) shall
`
`preclude In-House Counsel that becomes aware of “HIGHLY CONFIDENTIAL—OUTSIDE
`
`COUNSEL ONLY” information from participating in any prosecution, reexamination, PGR or
`
`IPR proceeding pertaining to fremanezumab, galcanezumab, or any other anti-CGRP antagonist
`
`antibody, provided however, that such In-House Counsel will not amend, draft or otherwise
`
`substantively assist in the drafting or amending of patent claims in any such proceedings.
`
`2
`
`
`
`Case 1:18-cv-12029-ADB Document 528 Filed 10/14/22 Page 3 of 6
`
`3.
`
`A copy of this amendment will be provided to all Third Parties who have produced
`
`information designated “HIGHLY CONFIDENTIAL—OUTSIDE COUNSEL ONLY.”
`
`IT IS SO ORDERED
`
`Dated:
`
`10/14/22
`
`Hon. Allison D. Burroughs
`United States District Judge
`
`3
`
`
`
`Case 1:18-cv-12029-ADB Document 528 Filed 10/14/22 Page 4 of 6
`
`Dated: October 13, 2022
`
`/s/ Elaine Herrmann Blais
`Douglas J. Kline (BBO# 556680)
`Kevin P. Martin (BBO# 655222)
`Elaine Herrmann Blais (BBO# 656142)
`Robert Frederickson III (BBO# 670111)
`Molly Grammel (BBO# 688439)
`Joshua S. Weinger (BBO# 690814)
`Alexandra Lu (BBO# 691114)
`Eric T. Romeo (BBO# 691591)
`Kathleen A. McGuinness (BBO# 693760)
`Tara R. Thigpen (BBO# 707508)
`GOODWIN PROCTER LLP
`100 Northern Avenue
`Boston, MA 02210
`Tel.: (617) 570-1000
`Fax: (617) 523-1231
`dkline@goodwinlaw.com
`kmartin@goodwinlaw.com
`eblais@goodwinlaw.com
`rfrederickson@goodwinlaw.com
`mgrammel@goodwinlaw.com
`jweinger@goodwinlaw.com
`alu@goodwinlaw.com
`eromeo@goodwinlaw.com
`kmcguinness@goodwinlaw.com
`tthigpen@goodwinlaw.com
`
`Natasha E. Daughtrey (pro hac vice)
`Sean M. Anderson (pro hac vice)
`GOODWIN PROCTER LLP
`601 S. Figueroa St.
`Los Angeles, CA 90017
`Tel.: (213) 426-2500
`Fax: (213) 623-1673
`ndaughtrey@goodwinlaw.com
`sanderson@goodwinlaw.com
`
`
`Respectfully submitted,
`
`s/ Andrea L. Martin (with permission)
`Andrea L. Martin (BBO 666117)
`BURNS & LEVINSON LLP
`125 High Street
`Boston, MA 02110-1624
`(617) 345-3000
`amartin@burnslev.com
`
`Charles E. Lipsey
`Ryan O’Quinn
`FINNEGAN, HENDERSON, FARABOW,
`GARRETT & DUNNER, LLP
`1875 Explorer Street
`Suite 800
`Reston, VA 20190-6023
`Charles.Lipsey@finnegan.com
`Oquinnr@finnegan.com
`
`Emily R. Gabranski (BBO 694417)
`Marta Garcia Daneshvar
`Lulu Wang (BBO 704042)
`FINNEGAN, HENDERSON, FARABOW,
`GARRETT & DUNNER, LLP
`2 Seaport Lane
`Boston, MA 02210-2001
`Emily.Gabranski@finnegan.com
`Marta.Garcia@finnegan.com
`Lulu.Wang@finnegan.com
`
`William B. Raich
`Denise Main
`Danielle A. Duszczyszyn
`Pier D. DeRoo
`Matthew J. Luneack
`Yoonjin Lee
`Sydney Kestle
`FINNEGAN, HENDERSON, FARABOW,
`GARRETT & DUNNER, LLP
`901 New York Avenue, NW
`Washington, DC 20001-4413
`William.Raich@finnegan.com
`Denise.Main@finnegan.com
`Danielle.Duszczyszyn@finnegan.com
`Pier.Deroo@finnegan.com
`
`
`
`Case 1:18-cv-12029-ADB Document 528 Filed 10/14/22 Page 5 of 6
`
`Madeline R. DiLascia (pro hac vice)
`GOODWIN PROCTER LLP
`1900 N Street N.W.
`Washington, D.C. 20036
`Tel.: (202) 346-4000
`Fax: (202) 204-7250
`mdilascia@goodwinlaw.com
`
`Attorneys for Plaintiffs
`
`Matthew.Luneack@finnegan.com
`Yoonjin.Lee@finnegan.com
`Sydney.Kestle@finnegan.com
`
`Attorneys for Defendant Eli Lilly and
`Company
`
`
`
`Case 1:18-cv-12029-ADB Document 528 Filed 10/14/22 Page 6 of 6
`
`CERTIFICATE OF SERVICE
`
`I, Elaine Herrmann Blais, hereby certify that this document filed through the ECF system
`
`will be sent electronically to the registered participants as identified on the Notice of Electronic
`
`Filing (“NEF”) and paper copies will be sent to those indicated as non-registered participants on
`
`October 13, 2022.
`
`
`
`
`/s/ Elaine Herrmann Blais
`Elaine Herrmann Blais (BBO# 656142)
`GOODWIN PROCTER LLP
`100 Northern Avenue
`Boston, MA 02210
`Tel.: (617) 570-1000
`Fax: (617) 523-1231
`eblais@goodwinlaw.com
`
`
`
`